Trajanoski Z - Search Results

1

New strategies for cancer immunotherapy: targeting regulatory T cells.

Finotello F, Trajanoski Z. Finotello F, et al. Among authors: trajanoski z. Genome Med. 2017 Jan 27;9(1):10. doi: 10.1186/s13073-017-0402-8. Genome Med. 2017. PMID: 28129791 Free PMC article.

2

Bioinformatics for cancer immunology and immunotherapy.

Charoentong P, Angelova M, Efremova M, Gallasch R, Hackl H, Galon J, Trajanoski Z. Charoentong P, et al. Among authors: trajanoski z. Cancer Immunol Immunother. 2012 Nov;61(11):1885-903. doi: 10.1007/s00262-012-1354-x. Epub 2012 Sep 18. Cancer Immunol Immunother. 2012. PMID: 22986455 Free PMC article. Review.

3

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer.

Trajanoski Z, Maccalli C, Mennonna D, Casorati G, Parmiani G, Dellabona P. Trajanoski Z, et al. Cancer Immunol Immunother. 2015 Jan;64(1):99-104. doi: 10.1007/s00262-014-1599-7. Epub 2014 Aug 28. Cancer Immunol Immunother. 2015. PMID: 25164877 Free PMC article. Review.

4

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy.

Angelova M, Charoentong P, Hackl H, Fischer ML, Snajder R, Krogsdam AM, Waldner MJ, Bindea G, Mlecnik B, Galon J, Trajanoski Z. Angelova M, et al. Among authors: trajanoski z. Genome Biol. 2015 Mar 31;16(1):64. doi: 10.1186/s13059-015-0620-6. Genome Biol. 2015. PMID: 25853550 Free PMC article.

5

Computational genomics tools for dissecting tumour-immune cell interactions.

Hackl H, Charoentong P, Finotello F, Trajanoski Z. Hackl H, et al. Among authors: trajanoski z. Nat Rev Genet. 2016 Jul 4;17(8):441-58. doi: 10.1038/nrg.2016.67. Nat Rev Genet. 2016. PMID: 27376489 Review.

6

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.

Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z. Charoentong P, et al. Among authors: trajanoski z. Cell Rep. 2017 Jan 3;18(1):248-262. doi: 10.1016/j.celrep.2016.12.019. Cell Rep. 2017. PMID: 28052254 Free article.

7

TIminer: NGS data mining pipeline for cancer immunology and immunotherapy.

Tappeiner E, Finotello F, Charoentong P, Mayer C, Rieder D, Trajanoski Z. Tappeiner E, et al. Among authors: trajanoski z. Bioinformatics. 2017 Oct 1;33(19):3140-3141. doi: 10.1093/bioinformatics/btx377. Bioinformatics. 2017. PMID: 28633385 Free PMC article.

8

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy.

Efremova M, Finotello F, Rieder D, Trajanoski Z. Efremova M, et al. Among authors: trajanoski z. Front Immunol. 2017 Nov 28;8:1679. doi: 10.3389/fimmu.2017.01679. eCollection 2017. Front Immunol. 2017. PMID: 29234329 Free PMC article. Review.

9

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution.

Efremova M, Rieder D, Klepsch V, Charoentong P, Finotello F, Hackl H, Hermann-Kleiter N, Löwer M, Baier G, Krogsdam A, Trajanoski Z. Efremova M, et al. Among authors: trajanoski z. Nat Commun. 2018 Jan 2;9(1):32. doi: 10.1038/s41467-017-02424-0. Nat Commun. 2018. PMID: 29296022 Free PMC article.

10

Quantifying tumor-infiltrating immune cells from transcriptomics data.

Finotello F, Trajanoski Z. Finotello F, et al. Among authors: trajanoski z. Cancer Immunol Immunother. 2018 Jul;67(7):1031-1040. doi: 10.1007/s00262-018-2150-z. Epub 2018 Mar 14. Cancer Immunol Immunother. 2018. PMID: 29541787 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters